Ahpra registration PHY0002298174
How these guides are written and reviewed →
A pleural effusion is a collection of fluid in the thin space between the lung and the chest wall. As fluid builds up it compresses the lung, causing breathlessness, chest discomfort and sometimes a dry cough. It is not a disease in itself but a sign of another problem — such as heart failure, infection or cancer — so finding and treating the cause matters. Draining the fluid often relieves symptoms quickly. This page explains pleural effusion and the physiotherapy that helps the lung re-expand.
Definition
The pleura are two thin membranes, one lining the lung and one the inside of the chest wall, normally separated by only a few millilitres of lubricating fluid. A pleural effusion is an abnormal accumulation of fluid in that space. It is not a disease in its own right but a sign of another problem — which is why finding the cause matters as much as removing the fluid.
Pathophysiology
Why fluid accumulates
Pleural fluid is continuously produced by the parietal pleura and reabsorbed by the parietal lymphatics. An effusion forms when production outstrips reabsorption, either because the driving pressures have changed or because the membrane itself has become leaky or the lymphatics blocked.
Transudate versus exudate
This distinction directs the entire diagnostic pathway. Transudates arise from altered hydrostatic or oncotic pressure with an intact pleura — heart failure, cirrhosis, nephrotic syndrome — and the fluid is protein-poor. Exudates arise from inflammation, infection or malignancy increasing capillary permeability or obstructing lymphatic drainage, and are protein-rich. A transudate points to a systemic problem to be treated medically; an exudate points to disease of the pleura or adjacent lung and usually requires further investigation.
Effect on breathing
Accumulating fluid does not simply compress the lung. It displaces the chest wall outwards and the diaphragm downwards and flattens it, placing the diaphragm at a mechanical disadvantage where it generates less pressure for the same effort. This is why breathlessness correlates poorly with effusion size, and why relief after drainage is often immediate and disproportionate to the volume removed — the diaphragm returns to a working length rather than the lung suddenly re-expanding.
Co-morbidities
Because effusions are secondary, they travel with their causes: heart failure, liver and kidney disease, pneumonia, malignancy, pulmonary embolism and autoimmune disease. Outcomes are shaped far more by the underlying condition than by the effusion itself, and a patient with recurrent effusions usually has advanced disease of some other organ. Coexisting COPD, obesity or frailty compound the breathlessness and slow recovery after drainage.
Prevalence
Pleural effusion is common, affecting hundreds of thousands of people annually in countries of comparable size to Australia. Heart failure is the single commonest cause, followed by pneumonia and malignancy. Malignant pleural effusion alone complicates a substantial proportion of advanced lung, breast and ovarian cancer and mesothelioma, and its incidence is rising as cancer survival lengthens.
Causes and risk factors
- Heart failure — the commonest cause overall; typically bilateral transudates.
- Infection — parapneumonic effusion and empyema; also tuberculous pleuritis.
- Malignancy — lung, breast, ovarian, lymphoma and mesothelioma.
- Pulmonary embolism — an under-recognised cause, and one that is missed if the effusion is assumed to explain the breathlessness.
- Liver and kidney disease — hepatic hydrothorax, nephrotic syndrome, dialysis.
- Post-surgical and post-cardiac injury — after cardiac or abdominal surgery.
- Autoimmune disease, pancreatitis, drugs and asbestos exposure — less common but important where the picture is atypical.
- Blood (haemothorax) or pus (empyema) — both need specific and urgent management rather than simple aspiration.
Symptoms
Typical features
- Breathlessness, usually on exertion first, worsening as the effusion enlarges and often positional.
- A dull ache, or sharp pleuritic pain if the parietal pleura is inflamed.
- A dry, non-productive cough.
- Reduced chest expansion, quiet breath sounds and stony dullness to percussion on the affected side.
Small versus large effusions
Small effusions frequently cause no symptoms at all and are found incidentally on imaging. Symptom burden depends more on the speed of accumulation and the state of the underlying lung than on volume: a rapidly forming small effusion in someone with poor reserve can be far more limiting than a large chronic one.
Warning signs
Diagnosis
Why diagnosis matters
Because an effusion is a marker of another disease, identifying its cause is as important as relieving the fluid. It directs treatment, and where the cause is malignancy, infection or pulmonary embolism, it is time-critical. Draining an effusion without establishing why it formed treats the symptom and misses the diagnosis.1
How is it diagnosed?
The sequence is imaging, then sampling, then targeted investigation of the cause. Bilateral effusions in clear-cut heart failure may reasonably be treated first and sampled only if they fail to resolve; unilateral effusions are sampled.
Radiology and ultrasound
Chest X-ray detects effusions above roughly 200 mL, showing blunting of the costophrenic angle and a meniscus. Thoracic ultrasound is more sensitive, distinguishes fluid from consolidation and pleural thickening, identifies septations, and should guide every pleural procedure — ultrasound guidance substantially reduces the risk of complications. CT with contrast, ideally before complete drainage, assesses the pleura for nodularity or thickening suggesting malignancy and examines the underlying lung.
Pleural aspiration and Light's criteria
Aspiration provides fluid for analysis. Light's criteria classify an effusion as exudative if any one of three thresholds is met: pleural-to-serum protein ratio above 0.5, pleural-to-serum lactate dehydrogenase ratio above 0.6, or pleural lactate dehydrogenase above two-thirds of the upper limit of the serum reference range.2 The criteria are highly sensitive for exudates but misclassify a minority of transudates — particularly in patients already on diuretics — where the serum-to-pleural albumin gradient resolves the discrepancy.
Investigations for related conditions
Fluid is sent for protein, lactate dehydrogenase, glucose, pH, cell count and differential, cytology and microbiology including mycobacterial culture. Cytology has moderate sensitivity for malignancy, so a negative result in a suspicious effusion prompts repeat sampling or pleural biopsy rather than reassurance. In parallel: echocardiography for heart failure, CT pulmonary angiography where embolism is possible, and liver, renal and autoimmune screening as indicated.
Management
Management and goals
The goals are to relieve breathlessness, establish and treat the cause, and — where the effusion will recur — choose a definitive strategy that minimises time spent in hospital. In malignant effusion particularly, the right question is not only how to drain it but how to keep the person out of hospital for the time they have.
Treating the cause
Diuretics for heart failure, antibiotics for infection, anticoagulation for embolism, and disease-directed therapy for malignancy or autoimmune disease. Transudates usually resolve when the underlying condition is controlled and rarely need repeated drainage.
Drainage
Therapeutic aspiration relieves symptoms quickly and can be done as a day procedure. Large-volume drainage is staged and limited — typically to about 1.5 L at a time, stopping earlier if chest discomfort or cough develops — to avoid re-expansion pulmonary oedema. An intercostal drain is used for large, infected or rapidly re-accumulating effusions.
Recurrent malignant effusions
Two definitive options exist and the choice is preference-sensitive. An indwelling pleural catheter allows drainage at home and relieves breathlessness as effectively as chest drain and talc pleurodesis, with fewer days in hospital.3 Compared directly with talc pleurodesis it significantly reduced total hospitalisation days.4 Where pleurodesis is chosen, analgesia and drain size influence the experience: opioid analgesia did not improve pain scores over non-steroidal anti-inflammatories, and smaller drains were more comfortable but slightly less effective at achieving pleurodesis.5
Identifying deterioration
Re-accumulating breathlessness, fever, increasing pain, purulent drainage from a catheter site, or a drain that stops working all warrant prompt review. New breathlessness immediately after large-volume drainage suggests re-expansion pulmonary oedema or pneumothorax and requires urgent imaging.
Action plan
Patients discharged with an indwelling catheter should have written drainage instructions, a supply schedule, a named contact for problems, and clear criteria for seeking help — fever, redness at the site, sudden breathlessness, or failure to drain. Those managed conservatively should know what re-accumulation feels like and who to call.
Medications
Medications directed at the cause
There is no drug that treats an effusion independently of its cause. Diuretics for cardiac effusions, antibiotics for infective ones, anticoagulation for embolism and cause-specific therapy for malignancy or autoimmune disease are the substance of drug treatment. Talc is used as a sclerosant for pleurodesis rather than as a systemic medication.
Analgesia and breathlessness
Pleuritic pain limits breathing depth and cough, so analgesia is prescribed with the respiratory consequence in mind. For refractory breathlessness in malignant effusion that has already been drained, low-dose opioids and non-pharmacological measures — a handheld fan, positioning, breathing control — are used within palliative care, and are effective where further drainage is not.
Living with a pleural effusion
Recovery after drainage
Many people feel dramatically better within hours of drainage. Mild chest discomfort and a dry cough for a day or two are expected. Fatigue is common and recovery of exercise tolerance takes longer than the relief of breathlessness suggests, particularly after a prolonged or infected effusion.
Living with an indwelling pleural catheter
Most people, or a family member or community nurse, manage drainage at home successfully after training. Practical concerns dominate: showering with the dressing, sleeping comfortably, clothing, and what to do if drainage stops. Spontaneous pleurodesis occurs in a proportion of patients, allowing the catheter to be removed.
Breathlessness management
Where breathlessness persists after the fluid is gone — common in malignancy and in coexisting lung disease — pacing, breathing control, positions of ease, a handheld fan and energy conservation are more useful than repeated imaging. Anxiety amplifies breathlessness and is addressed directly.
Activity and return to work
Activity is resumed as tolerated, with heavy lifting deferred after drain removal or surgery. A graded walking programme rebuilds capacity lost to weeks of breathlessness and inactivity.
Travel
Air travel is generally deferred until the effusion is resolved or definitively managed, and advice is individualised where an indwelling catheter is in place. Travel insurance disclosure matters for those with malignant effusion.
Prognosis
The outlook is that of the underlying condition. A parapneumonic effusion treated promptly resolves completely; a cardiac effusion resolves with control of heart failure. Malignant pleural effusion, by contrast, indicates advanced disease and median survival is measured in months, varying considerably by tumour type — which makes minimising hospital time a legitimate primary goal. Prompt drainage reliably relieves breathlessness whatever the cause, and re-accumulation is best managed proactively with a definitive plan rather than repeated emergency presentations.
Role of the physiotherapist
Physiotherapy supports lung re-expansion after drainage: thoracic expansion exercises, sustained maximal inspiration and incentive spirometry, using the active cycle of breathing technique for lung expansion, with positioning to favour the affected side. Understanding the mechanism matters here — breathlessness in effusion is driven substantially by diaphragm mechanics rather than by lung compression alone, and measured improvement follows the restoration of diaphragm position rather than fluid volume removed.6
Recovery and reconditioning follow: early mobilisation, shoulder and thoracic mobility on the affected side, posture, and graded exercise. Enhanced recovery pathways after thoracic intervention place structured respiratory physiotherapy and early mobilisation at their centre,7 with incentive spirometry as one component rather than a standalone treatment.8 Where the effusion was infective, the evidence for chest physiotherapy in uncomplicated pneumonia is limited,9 so effort is directed at lung expansion, mobilisation and reconditioning rather than routine percussion — and inpatient rehabilitation after pneumonia does improve functional capacity, muscle strength and quality of life.10
Breathlessness management is the third strand, and the one that matters most in malignant effusion: breathing control, pacing, positions of ease, fan therapy and anxiety management, delivered alongside palliative care where appropriate. Physiotherapy is also frequently the discipline that notices a re-accumulating effusion first, through a change in exercise tolerance reported before the next scan.
Part 1 · References
- Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society guideline for pleural disease. Thorax 2023;78(Suppl 3):s1–s42.
- Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77(4):507–513.
- Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion (TIME2): a randomized controlled trial. JAMA 2012;307(22):2383–2389.
- Thomas R, Fysh ETH, Smith NA, et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion (AMPLE): a randomized clinical trial. JAMA 2017;318(19):1903–1912.
- Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion (TIME1): a randomized clinical trial. JAMA 2015;314(24):2641–2653.
- Muruganandan S, Azzopardi M, Thomas R, et al. The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion. Eur Respir J 2020;55(5):1900980.
- Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the ERAS Society and the European Society of Thoracic Surgeons. Eur J Cardiothorac Surg 2019;55(1):91–115.
- Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry: 2011. Respir Care 2011;56(10):1600–1604.
- Yang M, Yan Y, Yin X, et al. Chest physiotherapy for pneumonia in adults. Cochrane Database Syst Rev 2013;(2):CD006338.
- José A, Dal Corso S. Inpatient rehabilitation improves functional capacity, peripheral muscle strength and quality of life in patients with community-acquired pneumonia: a randomised trial. J Physiother 2016;62(2):96–102.
References are numbered in citation order (Vancouver/BMJ style) and were current at the time of writing. Guidelines are living documents — verify against the latest version before clinical use.
Supervised exercise, breathing technique and self-management education are the mainstay of cardiorespiratory physiotherapy for this condition.
Clinical evidence
Part 1 covers the same condition without the technical detail. What follows is the evidence base behind it, written for clinicians — the literature, the reasoning and the gaps.
For clinicians: this summary supports clinical reasoning and is not a protocol. Check current guidelines and local policy before applying it, and read it alongside the key references and guidelines directory.
Framing. Management of a pleural effusion turns on two questions — is it a transudate or an exudate, and is the breathlessness worth draining — with Light's criteria still the working discriminator and ultrasound-guided sampling and drainage the standard of care.1,2 Physiotherapy contributes nothing to fluid removal and everything to what surrounds it: positioning, mobility with a drain, thoracic and shoulder mechanics, and the rehabilitation of a patient who has usually been unwell for weeks.
Drainage and pleurodesis evidence
- Ultrasound guidance reduces pneumothorax and organ-puncture complications and is mandated for pleural procedures in current guidance.1
- In malignant effusion, indwelling pleural catheters and talc pleurodesis relieve breathlessness comparably, with catheters producing fewer hospital days — shown in TIME2 and confirmed in the Australian AMPLE trial.3,4
- Smaller-bore chest tubes (12F) cause less pain than 24F tubes for talc pleurodesis with similar efficacy, which changes how tolerable early mobilisation is.5
- Therapeutic aspiration relieves dyspnoea but the volume drained at one sitting is limited by symptoms and by the risk of re-expansion pulmonary oedema; breathlessness relief correlates poorly with volume removed when the lung is trapped.1,6
- Transudative effusions are treated by treating the cause — heart failure, hypoalbuminaemia, renal or hepatic disease — and drainage of a heart-failure effusion without diuresis simply invites recurrence.2
Rehabilitation evidence
- Early mobilisation with a chest drain in situ is safe and recommended in thoracic enhanced-recovery guidance; drains are not a reason for bed rest.7
- No lung-expansion modality is superior: deep breathing with an inspiratory hold, incentive spirometry and positive expiratory pressure perform similarly, so selection follows tolerance and pain.8
- Chest physiotherapy does not improve outcomes in pneumonia, which is the commonest cause of an exudative effusion — a further reason to concentrate on mobility rather than clearance.9
- Inpatient rehabilitation after community-acquired pneumonia improves functional capacity, strength and quality of life; the same reasoning applies to the deconditioned patient recovering from an effusion.10
Physiotherapy implications
- Position for oxygenation and comfort: upright, and in unilateral effusion test side-lying with the unaffected lung dependent, confirming the response with oximetry in that patient rather than assuming it.
- Mobilise with the drain — keep the system upright and below the insertion site, never clamp a bubbling drain, coordinate with nursing, and treat walking as the primary intervention.7
- Rebuild the hemithorax after drainage: thoracic expansion with an end-inspiratory hold on the affected side, side-flexion and rotation to reverse splinting, and full shoulder range on the drain side.
- Do not use airway clearance for the effusion itself. Treat clearance only where a coexisting airway or suppurative problem exists.9
- Get analgesia right first — splinted shallow breathing after drain insertion is usually inadequate pain relief, and that is a medical escalation.5
- Set expectations where the lung is trapped: expansion exercises will not re-expand an encased lung, and the goal becomes breathing efficiency, pacing and function.6
- Escalate new pleuritic pain with breathlessness after drainage (pneumothorax), sudden increased air leak or surgical emphysema, cough with pink frothy sputum during or after large-volume drainage (re-expansion oedema), or fever suggesting empyema.
Clinical reasoning
- Reduced expansion, stony dull percussion and absent breath sounds is a fluid sign, not a secretion sign — the distinction determines whether treatment is indicated.
- Breathlessness that does not improve after successful drainage suggests trapped lung, parenchymal disease, embolism or cardiac cause — report it rather than intensifying exercise.6
- Fever with a loculated, thick or purulent effusion is pleural infection and needs drainage plus intrapleural agents or surgery, not physiotherapy.1
- Recurrent effusion is a diagnostic question — malignancy, heart failure, or chronic infection — and repeated aspiration without a plan is poor care.
Evidence gaps
- No trial has evaluated physiotherapy specifically in pleural effusion; all practice is extrapolated from thoracic surgery and pneumonia populations.7,8
- Optimal timing and dose of thoracic expansion work after drainage is unknown.
- Whether early rehabilitation reduces residual pleural thickening or restriction has not been studied.
- Long-term functional outcomes after large or recurrent effusions are poorly described.
References for the clinical evidence summary
- Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society guideline for pleural disease. Thorax 2023;78(Suppl 3):s1–s42.
- Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77(4):507–513.
- Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion (TIME2): a randomized controlled trial. JAMA 2012;307(22):2383–2389.
- Thomas R, Fysh ETH, Smith NA, et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion (AMPLE): a randomized clinical trial. JAMA 2017;318(19):1903–1912.
- Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion (TIME1): a randomized clinical trial. JAMA 2015;314(24):2641–2653.
- Muruganandan S, Azzopardi M, Thomas R, et al. The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion. Eur Respir J 2020;55(5):1900980.
- Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the ERAS Society and the European Society of Thoracic Surgeons. Eur J Cardiothorac Surg 2019;55(1):91–115.
- Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry: 2011. Respir Care 2011;56(10):1600–1604.
- Yang M, Yan Y, Yin X, et al. Chest physiotherapy for pneumonia in adults. Cochrane Database Syst Rev 2013;(2):CD006338.
- José A, Dal Corso S. Inpatient rehabilitation improves functional capacity, peripheral muscle strength and quality of life in patients with community-acquired pneumonia: a randomised trial. J Physiother 2016;62(2):96–102.
Corrections: If something on this page is wrong, out of date or unclear, we want to know. Email reception@inspireclinic.au with the page name and what you believe is incorrect. Substantive corrections are made promptly, and the guide’s version and last-updated date are changed to reflect it.